This notion may be supported by our earlier report demonstrating a significantly lower ABCA1 mRNA expression for the increased risk genotype after LXR agonist stimulation in lymphoblastoid cell lines derived from non-AMD patients [23]. The gene discussed is ABCA1; the disease is age-related macular degeneration.